AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (1.2 MB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Series Review | Publishing Language: Chinese | Open Access

Multiple clinical effects of recombinant human growth hormone therapy

Bin ZHOU, Yu YANG( )
Department of Endocrinology, Genetics and Metabolism, Jiangxi Provincial Children's Hospital, Nanchang 330006, China
Show Author Information

Abstract

Recombinant human growth hormone (rhGH) is the main therapeutic approach for height improvement. In recent years, with deepening research and clinical practice, accumulating evidence indicates that rhGH exerts additional clinical benefits on body composition, lipid metabolism, the skeletal system, and cognitive function. This article systematically reviews the multiple clinical effects of rhGH to provide a reference for optimizing treatment strategies and improving long-term health outcomes in patients.

References

【1】
【1】
 
 
Chinese Journal of Contemporary Pediatrics
Pages 797-804

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
ZHOU B, YANG Y. Multiple clinical effects of recombinant human growth hormone therapy. Chinese Journal of Contemporary Pediatrics, 2026, 28(7): 797-804. https://doi.org/10.7499/j.issn.1008-8830.2601142

2

Views

0

Downloads

0

Crossref

0

Scopus

0

CSCD

Received: 19 January 2026
Accepted: 30 June 2026
Published: 15 July 2026
© Editorial Office of Chinese Journal of Contemporary Pediatrics.

OA under CC BY-NC-ND 4.0 license